gatifloxacin has been researched along with Dysentery, Bacillary in 3 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Dysentery, Bacillary: DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Shigella infections are a leading cause of diarrhoeal death among children in low-income and middle-income countries." | 2.55 | Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis. ( Atlas, HE; Brander, RL; Pavlinac, PB; Pernica, JM; Tickell, KD; Walson, JL, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tickell, KD | 1 |
| Brander, RL | 1 |
| Atlas, HE | 1 |
| Pernica, JM | 1 |
| Walson, JL | 1 |
| Pavlinac, PB | 1 |
| Holt, KE | 1 |
| Thieu Nga, TV | 1 |
| Thanh, DP | 1 |
| Vinh, H | 2 |
| Kim, DW | 1 |
| Vu Tra, MP | 1 |
| Campbell, JI | 2 |
| Hoang, NV | 2 |
| Vinh, NT | 1 |
| Minh, PV | 2 |
| Thuy, CT | 2 |
| Nga, TT | 1 |
| Thompson, C | 1 |
| Dung, TT | 1 |
| Nhu, NT | 2 |
| Vinh, PV | 1 |
| Tuyet, PT | 1 |
| Phuc, HL | 1 |
| Lien, NT | 1 |
| Phu, BD | 1 |
| Ai, NT | 1 |
| Tien, NM | 1 |
| Dong, N | 1 |
| Parry, CM | 1 |
| Hien, TT | 1 |
| Farrar, JJ | 2 |
| Parkhill, J | 1 |
| Dougan, G | 1 |
| Thomson, NR | 1 |
| Baker, S | 2 |
| Anh, VT | 1 |
| Anh, ND | 1 |
| Nga, TV | 1 |
| Duy, PT | 1 |
| Phuong, le T | 1 |
| Loan, HT | 1 |
| Chinh, MT | 1 |
| Thao, NT | 1 |
| Tham, NT | 1 |
| Mong, BL | 1 |
| Bay, PV | 1 |
| Day, JN | 1 |
| Dolecek, C | 1 |
| Lan, NP | 1 |
| Diep, TS | 1 |
| Chau, NV | 1 |
| Wolbers, M | 1 |
1 review available for gatifloxacin and Dysentery, Bacillary
| Article | Year |
|---|---|
Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Child; Diarrhea; Dysentery, Bacillary; Fluoroquinolones; Gatifloxacin; Guidel | 2017 |
1 trial available for gatifloxacin and Dysentery, Bacillary
| Article | Year |
|---|---|
A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Dysentery, Bacillary; Feces; Female; Fluoroq | 2011 |
1 other study available for gatifloxacin and Dysentery, Bacillary
| Article | Year |
|---|---|
Tracking the establishment of local endemic populations of an emergent enteric pathogen.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Chromosomes, Bacterial; Ciprofloxacin; Dysentery, Ba | 2013 |